Polomar Health Services, Inc.
Polomar Health Services, Inc. (PMHS): 4 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.1 months
D/E -1.41 · 0% dilution
Lead: Preclinical
4 candidates
N/A
N/A
A transparent, data-derived signal for Polomar Health Services, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$2.6M
Cash
$88K
Quarterly Burn
$557K
Runway
1.1 mo
Revenue
$1.0M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| inhalable sildenafil | — |
| vigorair | Preclinical |
| vitaslim | — |
| vitaslim plus | — |
Frequently asked questions
How many drug candidates are in Polomar Health Services, Inc.'s pipeline?
Polomar Health Services, Inc. (PMHS) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Polomar Health Services, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Polomar Health Services, Inc. has approximately 1.1 months of cash runway.
What is Polomar Health Services, Inc.'s market capitalization?
Polomar Health Services, Inc.'s market capitalization is approximately $2.6M.
Who is the CEO of Polomar Health Services, Inc.?
Mr. Terrence M. Tierney J.D. is the chief executive officer of Polomar Health Services, Inc. (PMHS).
Get the full picture on Polomar Health Services, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.